Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2008 2
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Novel cytotoxic drugs: old challenges, new solutions.
Ismael GF, Rosa DD, Mano MS, Awada A. Ismael GF, et al. Cancer Treat Rev. 2008 Feb;34(1):81-91. doi: 10.1016/j.ctrv.2007.08.001. Epub 2007 Oct 1. Cancer Treat Rev. 2008. PMID: 17905518 Review.
Neuroendocrine tumors: a registry of 1,000 patients.
Younes RN; GETNE (Grupo de Estudo de Tumores Neuroendócrinos). Younes RN, et al. Rev Assoc Med Bras (1992). 2008 Jul-Aug;54(4):305-7. doi: 10.1590/s0104-42302008000400014. Rev Assoc Med Bras (1992). 2008. PMID: 18719787 Free article.
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients.
Gligorov J, Ataseven B, Verrill M, De Laurentiis M, Jung KH, Azim HA, Al-Sakaff N, Lauer S, Shing M, Pivot X; SafeHer Study Group. Gligorov J, et al. Eur J Cancer. 2017 Sep;82:237-246. doi: 10.1016/j.ejca.2017.05.010. Epub 2017 Jun 16. Eur J Cancer. 2017. PMID: 28625777 Clinical Trial.